E-health for Self-Management of Chronic Pain

Chronic Pain Clinical Trial

Official title:

Self-Management of Chronic Pain Using a Digital Pain-Management Tool.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04628650
• Other study ID #: US2
• Status: Completed
• Start date: May 1, 2021
• Est. completion date: June 1, 2022

Study information

• Verified date: February 2023
• Source: Lund University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators aim to validate if a digital tool for increased self-management of chronic pain can improve the quality of life for patients with chronic pain. The validation is based on the change in pain interference (Quality of life), pain intensity, physical functioning, depression, and anxiety based on self-reported information from baseline to study end.

Description:

Chronic pain is today an increasing health problem in both Europe and US, with an estimation of about 90 million people affected in Europe (Breivik, H. et al., 2006) and 100 million people in US (Relieving Pain in America, IOM Report 2011), or 20-30% of the adult population around the world. Chronic pain is defined as a condition that lasts for at least three to six months, after the normal healing period of an injury. Medical interventions offered in clinics around the globe are unfortunately not giving the results needed to give back the quality of life the patients had prior to the onset of the pain. The treatments offered today do sometimes reduce pain, but the effect is minor, and new treatment regimens are needed (Relieving Pain in America, 2011). Recent quality assurance registry measurements in Sweden has shown that patient taken part of multi modal treatment regimens, such as the acceptance and commitment therapy, (ACT) show that less then 40% of the patients have a decline in the pain level of 1 level on the VAS scale, 55% has no effect and 9 % has an increased level of pain after going through the program (Nationel Register for Pain Rehabilitation, Sweden 2017)

The study objective is to evaluate how the use of a digital pain coach, based on artificial intelligence that improves the self-management of pain will decrease the pain interference and thereby increase QoL among chronic pain patients, as measured by PROMIS pain interference 6a. We will here compare the improvement of quality of life by a decrease in pain interference, measured by PROMIS, in patients who follow their traditional treatment plan provided by the Pain Clinic with the addition of using a web application for increased self management of pain. The theory behind the study and the development of the device is supported by previously known data, showing that self-management has an effect and is important to the treatment by helping patients to believe in their own capacity to control their pain.

The present investigation aims at exploring the effect of including a digital tool as an add on to standard treatment and rehabilitation and will measure the effect it has on:

1. Decreased pain interference

2. Improved management of long-term pain and its consequences. Hence self-management of pain

3. Increased function in daily life with the best possible activity and participation level

4. Improved experience of health-related quality of life

5. Decreased pain experience

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: June 1, 2022
• Est. primary completion date: May 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Have a complex, prolonged axial neck pain or lower back pain

• Have been followed by a pain management specialist for at least 3 months or have a history of chronic pain for at least 3 months as recorded by physician

• Be >18 years of age

• Have a goal and motivation that is adequate in relation to the program offered

• Be medically prepared

• Have no major change in interventional treatment or be a surgical candidate

• Own a smart phone, tablet or computer or have the knowledge to use one

Exclusion Criteria:

• Chronic pain requiring imminent surgical intervention

• Reported severe or acute psychiatric illness, severe anxiety or depression

• Current history of substance abuse

• Serious health risks or scheduled major health interventions for other medical reasons

• Pain related to malignancy

• Pain duration <3 months

• Other areas of pain exceeding the amount of back or neck pain

• Not currently involved in lawsuit or pending litigation

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Device:
• Digital Pain-Management Tool
Self management digital tool for chronic pain

Locations

Country	Name	City	State
United States	Weill Cornell Medicine	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Lund University	Weill Medical College of Cornell University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain interference	Change from baseline in pain interference (QoL), measured by PROMIS Pain Interference 6a .; Measure of the amount of interference pain causes in life; range 6-30; higher is worse	6 and 12 weeks from baseline
Secondary	Pain severity	Change from Baseline in the 7 day average pain intensity. Measured by NRS using an 11-point Pain Intensity Numerical Rating Scale (NRS) (0=no pain, 10=pain as bad as you can imagine)	6 and 12 weeks from baseline
Secondary	Physical function	Change from baseline in physical function, measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Physical function 10a.; Measure of the impact of a condition on physical function; range 4-20; higher is worse	6 and 12 weeks from baseline
Secondary	Depression	Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression 4a.; Measures the extent to which patients experience depressive symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of depression	6 and 12 weeks from baseline
Secondary	Anxiety	Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Anxiety 4.; Measures the extent to which patients experience anxiety symptoms over the past 7 days. Raw scores range from 4-20 with lower scores representing less endorsement of anxiety.	6 and 12 weeks from baseline